CRISPR-Cas9 for selective targeting of somatic mutations in pancreatic cancers
{{output}}
Somatic mutations are desirable targets for selective elimination of cancer, yet most are found within noncoding regions. We have adapted the CRISPR-Cas9 gene editing tool as a novel, cancer-specific killing strategy by targeting the subset of somatic mutation... ...
